There are a significant number of relatively long-term news items in today’s report. Of most immediate interest to the majority of prostate cancer patients and educators we include reports on:
- The fact that over 70 percent of cancers thought to be unilateral at biopsy turn out to be bilateral post-surgery (which has implications for focal therapy)
- The availability of degarelix for actual prescription and clinical use in the USA
- The formation of a specialized new urologic oncology research institute at UCLA … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, curcumin, Degarelix, focal therapy, nanoparticles, PROMIS, sexual function, TRAIL | 3 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 